On-Demand-Webinar
Optimaler Einsatz der OCT für das Glaukom-Management; Porto, WGC 2023
Weiterentwicklungen beim Behandlungsansatz
11 Dezember 2023
· 9 Min. Videodauer
![Sofia Porto Castro, MD Sofia Porto Castro, MD]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/2310-optimizing-oct-usage-in-glaucoma-management/sofia_porto_pic.jpg/_jcr_content/renditions/original.image_file.100.100.223,10,1267,1054.file/sofia_porto_pic.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/2310-optimizing-oct-usage-in-glaucoma-management/sofia_porto_pic.jpg/_jcr_content/renditions/original.image_file.360.360.223,10,1267,1054.file/sofia_porto_pic.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/2310-optimizing-oct-usage-in-glaucoma-management/sofia_porto_pic.jpg/_jcr_content/renditions/original.image_file.768.768.223,10,1267,1054.file/sofia_porto_pic.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/2310-optimizing-oct-usage-in-glaucoma-management/sofia_porto_pic.jpg/_jcr_content/renditions/original.image_file.1024.1024.223,10,1267,1054.file/sofia_porto_pic.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/2310-optimizing-oct-usage-in-glaucoma-management/sofia_porto_pic.jpg/_jcr_content/renditions/original.image_file.1044.1044.223,10,1267,1054.file/sofia_porto_pic.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/2310-optimizing-oct-usage-in-glaucoma-management/sofia_porto_pic.jpg/_jcr_content/renditions/original.image_file.1044.1044.223,10,1267,1054.file/sofia_porto_pic.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/2310-optimizing-oct-usage-in-glaucoma-management/sofia_porto_pic.jpg/_jcr_content/renditions/original.image_file.1044.1044.223,10,1267,1054.file/sofia_porto_pic.jpg"})
Autor
Sofia Porto Castro MD
Zusammenfassung
Glaukom-Management nach der Früherkennung
Vorteile von CIRRUS OCT für die Glaukom-Früherkennung und die Bedeutung der zuverlässigen Beurteilung der Glaukomprogression anhand von klinischen Beispielen.